Fátima Ventura, 

Pharmacist, PhD in Biochemistry, Assistant Professor and member of the Metabolism, Genetics and Proteins in Health & Disease Group from iMed, Research Institute of Medicines, both at the Faculty of Pharmacy of the University of Lisboa.
Since 2007 is under service commission at INFARMED - National Authority of Medicines and Health Products, I.P., where is the current Head of the Scientific Evaluation Unit of the Medicines from the Medicines Evaluation Department. Since 2010 is a member of the Medicines Evaluation Committee from INFARMED.
From 2016 until 2024 was the alternate member for Portugal at the Committee for Medicinal Products for Human Use (CHMP) from the European Medicines Unit (EMA). Is currently the member representing Portugal in this committee. Since 2016 is also the member representing the CHMP in the Healthcare Professionals Working Party (HCPWP) and the alternate member in the Patients and Consumers Working Party.
Since 2020 is the member representing INFARMED in the Technical Commission for the Vaccines against COVID-19 (CTVC) currently renamed Technical Commission for the Seasonal Vaccines (CTVS) from the Health General Directorate.
Has a scientific interest for Inborn Errors of Metabolism, in particular related with fatty acids metabolism and their underlying pathogenic mechanisms such as metabolites toxicity and protein misfolding and the search for new therapeutic strategies.